On October 19, 2021, MicroTech Medical (Hangzhou) Co., Ltd., which has been deeply engaged in the field of diabetes monitoring and treatment for more than ten years, was listed on the main board of the Stock Exchange of Hong Kong Limited ("the Stock Exchange"), becoming the 22nd enterprise listed in Yuhang District, Hangzhou. Mr. Zhang Zhenfeng, Mr. Jin Chengtao, and other leaders of Yuhang District, as well as representatives of multiple investors and sponsors, and colleagues from the company, witnessed this historic moment together. (Stock abbreviation Weitai Medical B, stock code: 2235. HK)

MicroTech Medical (Hangzhou) Co., Ltd. (hereinafter referred to as "MicroTech Medical") is offering 63529500 H-shares globally at a price of HKD 30.50 per share. The estimated net proceeds from the global offering are approximately HKD 1.815 billion (excluding overallocations). The company's public offering in Hong Kong has received a warm response, and the initial proposed offering shares have been slightly oversubscribed, equivalent to approximately 6.79 times the initial available 6353000 Hong Kong offering shares for subscription in the Hong Kong public offering; the international offering received a slight oversubscription, equivalent to approximately 4.9 times the total number of shares available for subscription based on the initial international offering.

The joint sponsors of MicroTech Medical are Goldman Sachs and CICC. The public offering also attracted well-known cornerstone investors, including Jingshun, UBS, Lilly, Qifeng Capital, HudsonBay, Tencent, Boyu Capital, Qingchi Capital, Octagon Investments, Aobo Capital, Sage Partners, and others.

Dr. Zheng Pan, Chairman of MicroTech Medical, stated in his speech at the celebration ceremony: "Today, MicroTech Medical has successfully listed on the main board of the Hong Kong Stock Exchange, and I am full of gratitude. I am grateful to the users, investors, government departments and leaders who have provided us with firm support along the way, as well as friends from all walks of life. Listing on the Hong Kong stock market is only a small step for MicroTech Medical, and the future of human health still needs us to explore the starry sky. We must act as fighters and never forget our original entrepreneurial aspirations. In this beautiful era, we will always forge ahead and sail towards the vast sea of stars in the future!"